跳至主要内容
临床试验/CTRI/2022/03/041315
CTRI/2022/03/041315尚未招募2 期

An Open Label Randomized Control Trial To Evaluate TheEfficacy Of Dadima And Shatavari Formulation In TheManagement Of Abnormal Uterine Bleeding In Adolescent Girls.

DRASHWINI NARAYAN KARANDIKAR0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Girls between 12-19 years
  • 2.After one year of menarche
  • 3.Having complaints of abnormal uterine bleeding : â?? irregular or scanty or excessive
  • bleeding and/or having inter menstrual bleeding or spotting.

排除标准

  • 1. Having other systemic diseases, severe anemia, congenital anomalies
  • 2. Severe malnourishment
  • 3. Excessive bleeding during menses causing hemodynamic instability and worsening the
  • general condition.
  • 4. Participant who misses 2 follow up.
  • 5. Participant willing to discontinue the treatment.

研究者

发起方
DRASHWINI NARAYAN KARANDIKAR

相似试验